193 related articles for article (PubMed ID: 23995269)
1. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.
Milde S; Fox AN; Freeman MR; Coleman MP
Sci Rep; 2013; 3():2567. PubMed ID: 23995269
[TBL] [Abstract][Full Text] [Related]
2. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.
Milde S; Gilley J; Coleman MP
Bioarchitecture; 2013; 3(5):133-40. PubMed ID: 24284888
[TBL] [Abstract][Full Text] [Related]
3. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2.
Milde S; Gilley J; Coleman MP
PLoS Biol; 2013; 11(4):e1001539. PubMed ID: 23610559
[TBL] [Abstract][Full Text] [Related]
6. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
Yamagishi Y; Tessier-Lavigne M
Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
[TBL] [Abstract][Full Text] [Related]
7. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.
Lukacs M; Gilley J; Zhu Y; Orsomando G; Angeletti C; Liu J; Yang X; Park J; Hopkin RJ; Coleman MP; Zhai RG; Stottmann RW
Exp Neurol; 2019 Oct; 320():112961. PubMed ID: 31136762
[TBL] [Abstract][Full Text] [Related]
8. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
[TBL] [Abstract][Full Text] [Related]
9. Identification of palmitoyltransferase and thioesterase enzymes that control the subcellular localization of axon survival factor nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2).
Milde S; Coleman MP
J Biol Chem; 2014 Nov; 289(47):32858-70. PubMed ID: 25271157
[TBL] [Abstract][Full Text] [Related]
10. Rescue of peripheral and CNS axon defects in mice lacking NMNAT2.
Gilley J; Adalbert R; Yu G; Coleman MP
J Neurosci; 2013 Aug; 33(33):13410-24. PubMed ID: 23946398
[TBL] [Abstract][Full Text] [Related]
11. Low levels of NMNAT2 compromise axon development and survival.
Gilley J; Mayer PR; Yu G; Coleman MP
Hum Mol Genet; 2019 Feb; 28(3):448-458. PubMed ID: 30304512
[TBL] [Abstract][Full Text] [Related]
12. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
13. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
Conforti L; Gilley J; Coleman MP
Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
[TBL] [Abstract][Full Text] [Related]
14. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons.
Gilley J; Coleman MP
PLoS Biol; 2010 Jan; 8(1):e1000300. PubMed ID: 20126265
[TBL] [Abstract][Full Text] [Related]
15. Sarm1 Deletion, but Not Wld
Gilley J; Ribchester RR; Coleman MP
Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
[TBL] [Abstract][Full Text] [Related]
16. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
[TBL] [Abstract][Full Text] [Related]
17. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
[TBL] [Abstract][Full Text] [Related]
18. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
[TBL] [Abstract][Full Text] [Related]
19. NMNAT2: An important metabolic enzyme affecting the disease progression.
Li W; Gao M; Hu C; Chen X; Zhou Y
Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916
[TBL] [Abstract][Full Text] [Related]
20. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
Gerdts J; Summers DW; Milbrandt J; DiAntonio A
Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]